PDT Partners’s Thermo Fisher Scientific TMO Stock Holding History

PDT Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,000	Closed	-$3.34M	–	1117
2021 Q4	$3.34M	Sell	5,000 -3,100	-38%	-$1.94M	0.25%	138
2021 Q3	$4.63M	Buy	+8,100	New	+$4.45M	0.33%	101
2021 Q1	–	Sell	-1,008	Closed	-$470K	–	883
2020 Q4	$470K	Buy	+1,008	New	+$473K	0.03%	457
2019 Q4	–	Sell	-32,509	Closed	-$9.47M	–	761
2019 Q3	$9.47M	Buy	32,509 +9	+0%	+$2.58K	0.56%	48
2019 Q2	$9.54M	Buy	+32,500	New	+$8.95M	0.56%	56
2016 Q3	–	Sell	-46,500	Closed	-$6.87M	–	515
2016 Q2	$6.87M	Buy	+46,500	New	+$6.86M	0.54%	70
2015 Q3	–	Sell	-23,241	Closed	-$3.02M	–	1562
2015 Q2	$3.02M	Buy	+23,241	New	+$3.03M	0.08%	304
2014 Q3	–	Sell	-19,701	Closed	-$2.33M	–	1589
2014 Q2	$2.33M	Sell	19,701 -83,795	-81%	-$9.86M	0.06%	395
2014 Q1	$12.4M	Buy	+103,496	New	+$12.3M	0.3%	88

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PDT Partners's TMO Position: Q1 2022 in Review

PDT Partners sold out of Thermo Fisher Scientific (TMO) in Q1 2022, closing a stake of 5,000 shares — an estimated $3.34M sold.

PDT Partners first reported a position in TMO in Q1 2014 and held it in 9 quarters. The position peaked at $12.4M in Q1 2014. 2,314 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

PDT Partners reported no remaining Thermo Fisher Scientific position as of Q1 2022 after selling out during the quarter.
PDT Partners sold 5,000 Thermo Fisher Scientific shares in Q1 2022, an estimated $3.34M.
PDT Partners first reported a position in Thermo Fisher Scientific in Q1 2014 and held it in 9 quarters.
PDT Partners's Thermo Fisher Scientific position peaked at $12.4M in Q1 2014.
2,314 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on PDT Partners's 13F filing for Q1 2022, filed 16 May 2022.